155 related articles for article (PubMed ID: 38466213)
1. Mirikizumab (Omvoh) for ulcerative colitis.
Med Lett Drugs Ther; 2024 Mar; 66(1698):46-47. PubMed ID: 38466213
[No Abstract] [Full Text] [Related]
2. Upadacitinib (Rinvoq): A second JAK inhibitor for ulcerative colitis.
Med Lett Drugs Ther; 2022 Sep; 64(1658):142-144. PubMed ID: 36094554
[No Abstract] [Full Text] [Related]
3. Etrasimod (Velsipity) for ulcerative colitis.
Med Lett Drugs Ther; 2023 Nov; 65(1690):187-189. PubMed ID: 37983118
[No Abstract] [Full Text] [Related]
4. Drugs for inflammatory bowel disease.
Med Lett Drugs Ther; 2023 Jul; 65(1680):105-112. PubMed ID: 37418329
[No Abstract] [Full Text] [Related]
5. Expanded table: Some drugs for inflammatory bowel disease.
Med Lett Drugs Ther; 2023 Jul; 65(1680):e115-e119. PubMed ID: 37418332
[No Abstract] [Full Text] [Related]
6. Ozanimod (Zeposia) for ulcerative colitis.
Med Lett Drugs Ther; 2021 Sep; 63(1633):147-151. PubMed ID: 34550962
[No Abstract] [Full Text] [Related]
7. Risankizumab (Skyrizi) - A
